Why the study?
Clinical use of the antineoplastic agent doxorubicin is limited by cardiotoxicity, prompting investigation into whether olmesartan, l-carnitine, or their combination provides cardioprotection.
Do olmesartan and l-carnitine protect against doxorubicin-induced cardiotoxicity in a rat model?
Do olmesartan and l-carnitine protect against doxorubicin-induced cardiotoxicity in a rat model?
Olmesartan and l-carnitine demonstrate protective effects against doxorubicin-induced cardiotoxicity in a rat model through antioxidant, anti-inflammatory, and antiapoptotic mechanisms.
Answers are grounded in this paper and cite their sources.
Should not yet change practice; leaves open human confirmation of this combination against doxorubicin cardiotoxicity.
Doxorubicin (DOX), an anthracycline antibiotic, is an important antineoplastic agent due to its high antitumor efficacy in hematological as well as in solid malignancies. The clinical use of DOX is limited due to its cardiotoxic effects. The present study aimed to investigate the possible protective effect of olmesartan (Olm), l-carnitine (L-CA), and their combination in cardiotoxicity induced by DOX in rats. Male albino rats were randomly divided into seven experimental groups (n = 8): group I: normal control, group II: L-CA, group III: Olm, group IV: DOX. The other three groups were treated with Olm (10 mg/kg), L-CA (300 mg/kg), and their combination for 2 weeks after induction of cardiotoxicity by a single dose of DOX (20 mg/kg). In the results, DOX showed a significant elevation in serum troponin I, creatine kinase-MB (CK-MB), and lactate dehydrogenase (LDH) together with increased inflammation manifested by the rise of tumor necrosis factor-alpha (TNF-α), intercellular adhesion molecules-1 (ICAM-1), interleukin IL-1β (IL-1β), myeloperoxidase (MPO), nuclear factor-kappa B (NF-κB), and transforming growth factor beta (TGF-β) in cardiac tissues as well as DOX-induced oxidative stress by increasing in malondialdehyde (MDA) and decreasing in superoxide dismutase (SOD) and glutathione (GSH) in heart tissues. In addition, caspase-3 activity was boosted as indication of increased apoptosis. On the other hand, administration of L-CA and Olm attenuated the DOX-evoked disturbances in the abovementioned parameters. In addition, DOX exhibited echocardiographic changes and severe histopathological changes, which were significantly reversed by L-CA and Olm treatment. In conclusion, the present study data confirm the protective role of L-CA and Olm in DOX-induced cardiotoxicity, which may be related to its antioxidant, antiinflammatory, and antiapoptotic agents.
No takes yet. Share an insight, caveat, or question.
Aziz et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: